CD19CAR-28-zeta T cells / Baylor College of Medicine - LARVOL DELTA

Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO) (clinicaltrials.gov) - P1 | N=7 | Active, not recruiting | Sponsor: Baylor College of Medicine | Recruiting ➔ Active, not recruiting | N=40 ➔ 7 | Trial completion date: Feb 2024 ➔ Dec 2030

Enrollment change • Enrollment closed • Trial completion date • Bone Marrow Transplantation • Chronic Lymphocytic Leukemia • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Transplantation • CD19